Episode 51: How Psilocybin Changed One Man’s Experience with Terminal Cancer | with Steve Allgood
MAPS Canada PodcastShow Notes
In this episode of the MAPS Canada Podcast, host Rielle Capler speaks with Steve Allgood about his experience navigating a terminal brain cancer diagnosis and the unexpected role psychedelics played in helping him confront fear, depression, and existential distress.
Steve shares the emotional reality of being diagnosed with terminal brain cancer just days before his wedding, the difficult process of radiation treatment, and the psychological toll of living under the belief that his life would soon end. The conversation explores his search for hope through alternative approaches to care, including high-dose cannabis and psilocybin mushrooms, and how these experiences gradually transformed his relationship to illness, suffering, and meaning.
The discussion also highlights the importance of emotional support, psychedelic safety, and reducing stigma around end-of-life care and alternative therapies. Through Steve’s deeply personal story, the episode offers insight into the growing conversation surrounding psychedelics, mental health, and quality of life for individuals facing serious illness.
Working with partners in government, business, and the community, MAPS Canada is committed to advancing psychedelic medicine by supporting scientific, multidisciplinary research; advocating for drug policy reform; offering public education; and supporting equitable access to legal and regulated psychedelic medicine in Canada.
The Multidisciplinary Association for Psychedelic Studies (MAPS) was formed in the US in 1986, in response to the US Drug Enforcement Agency’s classification of MDMA as Schedule 1 substance, and has been developing medical, legal, and cultural contexts for people to benefit from the careful uses of psychedelics since then.
MAPS Canada was founded as a sister organization to MAPS in 2011, and is a registered Canadian non-profit organization. Based in Vancouver and with hundreds of volunteers from across Canada, MAPS Canada is moving forward to become the leading Canadian source of information, resources and advocacy regarding psychedelic medicine and related clinical research, education, and public policy.
Learn More at https://mapscanada.org/about/
MAPS Canada is entirely funded by public donation and your support really makes a difference. Find out about all the ways you can support MAPS Canada’s mission by visiting our donation link https://mapscanada.org/donate/ Support MAPS Canada Podcast
More from MAPS Canada Podcast
Healing is often understood through the individual experience, but what might we learn by centring Indigenous perspectives on the deeply relational nature of psychedelic healing?
How can we better support Indigenous access to psychedelic-assisted healing, develop community-led models of care, and shape the future of psychedelic research in Canada?
What happens when psychedelic research moves beyond the traditional pharmaceutical model and becomes more patient-centred, grassroots, and responsive to the realities of how people are actually accessing these therapies?
What can we learn about psychedelics by studying how people actually use them in the real world?
In this episode of the MAPS Canada Podcast, host Matt Hamel speaks with occupational therapist Shel Scott about the emerging role of psychedelic-assisted therapy in the treatment of eating disorders. Drawing from her unique perspective as both an eating disorder survivor and a mental health clinician, Shel explores why eating disorders remain among the most challenging psychiatric conditions to treat, and where psychedelic medicines may offer new therapeutic possibilities.